Drug Companies Are Compromising the Health Care Safety Net

Drug companies are compromising the health care safety net

Chris Hondros/Getty ImagesTaxpayers, get ready for another round of bailouts. But, unlike Wall Street executives who begged Uncle Sam to cover their risky bets, cash-strapped nonprofit rural health care providers have not gambled away their resources. Quite the contrary, they have done nothing irresponsible. The best part is the bailout is not a fait accompli. The simplest way to protect providers is by codifying the critical savings that provid…

An Existential Threat to 340B Providers – MedLearn Publishing

My association, 340B Health, represents hospitals that participate in the federal 340B drug pricing program. It has been an incredibly busy summer, with many new proposals targeting 340B. I’m going to focus on two issues today. First, legislation was recently introduced in Congress to protect 340B hospitals from harmful drug company policies that have stripped billions of dollars from the healthcare safety net. And, second, the administration ju…

AHA defends HHS decision to reject 340B rebate models by drug companies

The AHA today filed an amicus brief in the U.S. Court of Appeals for the D.C. Circuit, defending the Department of Health and Human Services’ decision to prevent drug companies from implementing a 340B rebate model. The brief was filed in a consolidated appeal involving five drug companies. The AHA said such models from drug companies would devastate hospitals financially.   “In a world of finite resources, 340B hospitals will have no choice but…